Increased Osteoclast and Decreased Osteoblast Activity Causes Reduced Bone Mineral Density and Quality in Genetic Hypercalciuric Stone‐Forming Rats
Open Access
- 12 February 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in JBMR Plus
- Vol. 4 (4) , e10350
Abstract
To study human idiopathic hypercalciuria (IH), we developed an animal model, genetic hypercalciuric stone‐forming (GHS) rats, whose pathophysiology parallels that in IH. All GHS rats form kidney stones and have decreased BMD and bone quality compared with the founder Sprague–Dawley (SD) rats. To understand the bone defect, we characterized osteoclast and osteoblast activity in the GHS compared with SD rats. Bone marrow cells were isolated from femurs of GHS and SD rats and cultured to optimize differentiation into osteoclasts or osteoblasts. Osteoclasts were stained for TRAcP (tartrate resistant acid phosphatase), cultured to assess resorptive activity, and analyzed for specific gene expression. Marrow stromal cells or primary neonatal calvarial cells were differentiated to osteoblasts, and osteoblastic gene expression as well as mineralization was analyzed. There was increased osteoclastogenesis and increased resorption pit formation in GHS compared with SD cultures. Osteoclasts had increased expression of cathepsin K, Tracp, and MMP9 in cells from GHS compared with SD rats. Osteoblastic gene expression and mineralization was significantly decreased. Thus, alterations in baseline activity of both osteoclasts and osteoblasts in GHS rats, led to decreased BMD and bone quality, perhaps because of their known increase in vitamin D receptors. Better understanding of the role of GHS bone cells in decreased BMD and quality may provide new strategies to mitigate the low BMD and increased fracture risk found in patients with IH. © 2020 The Authors. JBMR Plus published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (RO1 DK075462)
This publication has 54 references indexed in Scilit:
- Nephrolithiasis-associated bone disease: pathogenesis and treatment optionsKidney International, 2011
- Calcium Kidney StonesNew England Journal of Medicine, 2010
- Elevated vitamin D receptor levels in genetic hypercalciuric stone-forming rats are associated with downregulation of SnailJournal of Bone and Mineral Research, 2010
- Genetic Hypercalciuric Stone-Forming Rats Have a Primary Decrease in BMD and StrengthJournal of Bone and Mineral Research, 2009
- RANKL Is a Mediator of Bone Resorption in Idiopathic HypercalciuriaClinical Journal of the American Society of Nephrology, 2008
- Thiazides Reduce Brushite, but not Calcium Oxalate, Supersaturation, and Stone Formation in Genetic Hypercalciuric Stone–Forming RatsJournal of the American Society of Nephrology, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- New insights into the pathogenesis of idiopathic hypercalciuria: The role of boneKidney International, 1996
- Response of genetic hypercalciuric rats to a low calcium dietKidney International, 1993
- Mechanism of hypercalciuria in genetic hypercalciuric rats. Inherited defect in intestinal calcium transport.Journal of Clinical Investigation, 1988